Aconitum Napellus Whole Bryonia Alba Root Ferrosof
| Evidence Level: L5 | Predicted Indications: 0 |
Table of Contents
- Aconitum Napellus Whole Bryonia Alba Root Ferrosof
- Multi-Component Homeopathic Remedy (9 Ingredients): Unable to Generate Drug Repurposing Predictions
Multi-Component Homeopathic Remedy (9 Ingredients): Unable to Generate Drug Repurposing Predictions
One-Sentence Summary
This product is a multi-component homeopathic remedy containing 9 ingredients (including Aconitum napellus, Bryonia alba, Pulsatilla vulgaris and other plant-derived and mineral-derived ingredients), with no approved marketing records in the United States market, and unable to complete DrugBank ID matching. Since the TxGNN model cannot perform standardized mapping for this combination product, there are currently no predicted indications, and related clinical trials and literature evidence are lacking.
Quick Overview
| Item | Content |
|---|---|
| Original Indications | No records |
| Predicted New Indications | None (TxGNN unable to generate predictions) |
| TxGNN Prediction Score | None |
| Evidence Level | Unable to assess |
| US Market Status | Not marketed |
| NDA Count | 0 |
| Recommended Decision | Hold |
Why Can’t Predictions Be Completed?
This product is a multi-ingredient combination homeopathic remedy containing the following 9 components:
- Aconitum napellus (whole plant)
- Bryonia alba (root)
- Ferrosoferric phosphate
- Lycopodium clavatum (spores)
- Oyster shell calcium carbonate (crude)
- Phosphorus
- Pulsatilla vulgaris (whole plant)
- Rancid beef
- Sulfur
The TxGNN model bases predictions on single chemical entities recorded in DrugBank. Because this product:
- Lacks a DrugBank ID: Multi-component homeopathic remedy combinations are typically not recorded in DrugBank
- Components are at extremely low dilution concentrations: In accordance with homeopathic preparation principles, the active ingredient content in homeopathic remedies is far below the threshold for pharmacological effect
- Lacks standardized INN: The combination of 9 ingredients does not have a corresponding International Nonproprietary Name
These factors prevent TxGNN from establishing knowledge graph node mapping, thus no drug repurposing candidates were generated.
US Market Information
This product has no approved drug licenses (NDA/ANDA) in the United States; its US market status is Not marketed.
Safety Considerations
Please refer to the individual package inserts for each ingredient, noting the following potential risks:
- Aconitum napellus: Contains aconitine; the parent plant is highly toxic, and overdose can cause cardiac arrhythmias and death; although homeopathic remedies are highly diluted, care must be taken regarding preparation quality
- Phosphorus: High doses have hepatotoxic effects
Since this product lacks comprehensive package insert warnings and contraindication information, detailed safety information should be obtained elsewhere.
Conclusions and Next Steps
Decision: Hold
Rationale: This product is a multi-component homeopathic remedy without a DrugBank record. The TxGNN model cannot generate predictions; moreover, lacking US approval records, MOA information, and package insert safety data, there are currently insufficient baseline data conditions to perform drug repurposing assessment.
To continue evaluation, the following information needs to be supplemented:
- Clarify assessment objectives: Confirm whether evaluation targets individual ingredients (such as Aconitum napellus, Pulsatilla vulgaris) rather than the overall combination product
- Obtain DrugBank IDs for each component: Separately search for DrugBank record status for each of the 9 ingredients
- Confirm remedy dilution ratio: The dilution ratio of the homeopathic remedy (such as 6X, 30C) determines whether there is pharmacological relevance
- Supplement safety data: Download and analyze existing package inserts (if available), or search published toxicology data for each ingredient
- Re-run TxGNN: Submit each individual ingredient separately by INN to obtain individual drug repurposing prediction results for each
⚠️ The results in this report are for research reference only and do not constitute medical advice. Drug repurposing candidates require clinical validation before application.
Disclaimer
This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.